ArticleCentral-European journal of immunology2021

Severe hypereosinophilic syndrome successfully treated with a monoclonal antibody against interleukin 5 receptor α - benralizumab.

Joanna Kosałka-Węgiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.